Bank of America’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.54M Buy
272,629
+32,982
+14% +$913K ﹤0.01% 2973
2025
Q1
$5.32M Buy
239,647
+23,875
+11% +$530K ﹤0.01% 3158
2024
Q4
$4.27M Buy
215,772
+4,654
+2% +$92.1K ﹤0.01% 3162
2024
Q3
$5.28M Sell
211,118
-3,729
-2% -$93.2K ﹤0.01% 3153
2024
Q2
$4.01M Buy
214,847
+2,342
+1% +$43.7K ﹤0.01% 3264
2024
Q1
$4.19M Buy
212,505
+161,962
+320% +$3.2M ﹤0.01% 3187
2023
Q4
$887K Sell
50,543
-62,016
-55% -$1.09M ﹤0.01% 4224
2023
Q3
$1.96M Buy
112,559
+20,325
+22% +$353K ﹤0.01% 3558
2023
Q2
$1.3M Sell
92,234
-96,785
-51% -$1.36M ﹤0.01% 3837
2023
Q1
$2.03M Buy
189,019
+34,573
+22% +$372K ﹤0.01% 3702
2022
Q4
$2.31M Buy
154,446
+128,298
+491% +$1.92M ﹤0.01% 3550
2022
Q3
$336K Buy
26,148
+579
+2% +$7.44K ﹤0.01% 4905
2022
Q2
$247K Sell
25,569
-6,493
-20% -$62.7K ﹤0.01% 5196
2022
Q1
$319K Sell
32,062
-99,520
-76% -$990K ﹤0.01% 5408
2021
Q4
$1.55M Buy
131,582
+91,030
+224% +$1.07M ﹤0.01% 4132
2021
Q3
$462K Buy
40,552
+6,532
+19% +$74.4K ﹤0.01% 4920
2021
Q2
$474K Sell
34,020
-24,852
-42% -$346K ﹤0.01% 4759
2021
Q1
$1.09M Buy
58,872
+32,720
+125% +$606K ﹤0.01% 4184
2020
Q4
$462K Sell
26,152
-245,052
-90% -$4.33M ﹤0.01% 4379
2020
Q3
$4.16M Buy
271,204
+10,623
+4% +$163K ﹤0.01% 2709
2020
Q2
$6.64M Buy
260,581
+92,390
+55% +$2.35M ﹤0.01% 2322
2020
Q1
$2.6M Buy
168,191
+12,686
+8% +$196K ﹤0.01% 2913
2019
Q4
$1.72M Buy
155,505
+19,993
+15% +$221K ﹤0.01% 3532
2019
Q3
$1.15M Buy
135,512
+126,569
+1,415% +$1.08M ﹤0.01% 3789
2019
Q2
$121K Buy
8,943
+4,854
+119% +$65.7K ﹤0.01% 5149
2019
Q1
$74K Sell
4,089
-7,542
-65% -$136K ﹤0.01% 5273
2018
Q4
$327K Buy
11,631
+10,594
+1,022% +$298K ﹤0.01% 4512
2018
Q3
$27K Buy
+1,037
New +$27K ﹤0.01% 5667